Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban

Am J Emerg Med. 2015 May;33(5):739.e5-6. doi: 10.1016/j.ajem.2014.11.027. Epub 2014 Nov 28.

Authors

Zachary Hourmouzis¹, Mary Colleen Bhalla², Jennifer A Frey¹, Sharhabeel Jwayyed³

Affiliations

¹ Department of Emergency Medicine, Summa Akron City Hospital, Akron, OH, USA.
² Department of Emergency Medicine, Summa Akron City Hospital, Akron, OH, USA; Northeast Ohio Medical University, Rootstown, OH, USA. Electronic address: bhallam@summahealth.org.
³ Department of Emergency Medicine, Summa Akron City Hospital, Akron, OH, USA; Northeast Ohio Medical University, Rootstown, OH, USA.

PMID: 25497698
DOI: 10.1016/j.ajem.2014.11.027

No abstract available

Publication types

Case Reports

MeSH terms

Antithrombins*
Arginine / analogs & derivatives
Female
Fibrinolytic Agents / therapeutic use*
Heparin / adverse effects*
Humans
Middle Aged
Pipecolic Acids / therapeutic use*
Pulmonary Embolism / chemically induced*
Pulmonary Embolism / drug therapy*
Sulfonamides
Thrombocytopenia / chemically induced*
Thrombocytopenia / drug therapy*
Tissue Plasminogen Activator / therapeutic use*

Substances

Antithrombins
Fibrinolytic Agents
Pipecolic Acids
Sulfonamides
Heparin
Arginine
Tissue Plasminogen Activator
argatroban